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BACKGROUND: The exstrophy-epispadias complex (BEEC) is a urogenital birth defect of varying severity.
The causes of the BEEC are likely to be heterogeneous, with individual environmental or genetic risk factors
still being largely unknown. In this study, we aimed to identify de novo causative copy number variations
(CNVs) that contribute to the BEEC. METHODS: Array-based molecular karyotyping was performed to
screen 110 individuals with BEEC. Promising CNVs were tested for de novo occurrence by investigating
parental DNAs. Genes located in regions of rearrangements were prioritized through expression analysis in
mice to be sequenced in the complete cohort, to identify high-penetrance mutations involving small
sequence changes. RESULTS: A de novo 0.9 Mb microduplication involving chromosomal region 19p13.12
was identified in a single patient. This region harbors 20 validated RefSeq genes, and in situ hybridization
data showed specific expression of the Wiz gene in regions surrounding the cloaca and the rectum between
GD 9.5 and 13.5. Sanger sequencing of the complete cohort did not reveal any pathogenic alterations affect-
ing the coding region of WIZ. CONCLUSIONS: The present study suggests chromosomal region 19p13.12 as
possibly involved in the development of CBE, but further studies are needed to prove a causal relation. The
spatiotemporal expression patterns determined for the genes encompassed suggest a role for Wiz in the
development of the phenotype. Our mutation screening, however, could not confirm that WIZ mutations are
a frequent cause of CBE, although rare mutations might be detectable in larger patient samples.
19p13.12, microduplication, bladder exstrophy-epispadias complex, array-based molecular karyotyping, in
situ hybridization analysis, copy number variations, WIZ gene Birth Defects Research (Part A) 97:133–139,
2013.  2013 Wiley Periodicals, Inc.
Markus Draaken and Sadaf S. Mughal contributed equally to this
work.
Markus Draaken, Sadaf S. Mughal, Tracie Pennimpede, Lars Wittler,
Anne-Karoline Ebert, Wolfgang Ro¨sch, Raimund Stein, Enrika Bartels,
Dominik Schmidt, Thomas M. Boemers, Eberhard Schmiedeke, Per
Hoffmann, Bernhard G. Herrmann, Markus M. No¨then, Heiko Reut-
ter, and Michael Ludwig are members of the ‘‘Network for the Sys-
tematic Investigation of the Molecular Causes, Clinical Implications
and Psychosocial Outcome of Congenital Uro-Rectal Malformations
(CURE-Net)’’ which is supported by a research grant from the
BMBF.
Supported by grant from the German Federal Ministry of Education and
Research (Bundesministerium fu¨r Bildung und Forschung, BMBF;
01GM08107), the BONFOR program of the University of Bonn (O-
149.0099 to EB), and the Richard-Winter-Stiftung (to SSM).
*Correspondence to: Michael Ludwig, Department of Clinical Chemistry and
Clinical Pharmacology, University of Bonn, Sigmund-Freud-Str. 25, D-53127
Bonn, Germany. E-mail: mludwig@uni-bonn.de
Published online 29 January 2013 in Wiley Online Library (wileyonlinelibrary.
com).
DOI: 10.1002/bdra.23112
Birth Defects Research (Part A): Clinical and Molecular Teratology 97:133139 (2013)
 2013 Wiley Periodicals, Inc. Birth Defects Research (Part A) 97:133139 (2013)
INTRODUCTION
The clinical presentation of the bladder-exstrophy-
epispadias complex (BEEC) ranges from epispadias (E)
and classical bladder exstrophy (CBE), to the most severe
form, cloacal exstrophy (CE), often referred to as the
OEIS complex (omphalocele, exstrophy, imperforate
anus, and spinal defects) (Carey, 2001; Gearhart, 2002).
The incidence for the complete spectrum has been
reported to be 1 in 10,000 live births, with multiple sur-
veys stating a male-to-female ratio of 2.4:1 (Ebert et al.,
2009). Although its etiology is still unclear, there is vast
evidence that the BEEC has a strong genetic contribution:
(i) a 400-fold increase in the recurrence risk for offspring
of BEEC affected individuals (Shapiro et al., 1984), (ii) the
existence of multiplex families (Ludwig et al., 2009), and
(iii) higher concordance rates among monozygous com-
pared with dizygous twins (62% vs. 11%; Reutter et al.,
2007). Furthermore, instances of associated numeric or
structural chromosomal aberrations currently in 12 cases
support a genetic background involvement in the BEEC
(Rotmensch et al., 1991; Battaglia et al., 1999; Ludwig
et al., 2009; Draaken et al., 2010; El-Hattab et al., 2010;
Lundin et al., 2010; Zaki et al., 2012).
The aim of the present study was to identify causative
de novo microaberrations characterized by loss or gain of
genomic material (i.e., copy number variations [CNVs]),
which may contribute to the BEEC at a genome-wide
level. Molecular karyotyping was performed in 110 cases
exhibiting BEEC. This analysis and subsequent quantita-
tive PCR (qPCR) analysis of parental DNA revealed a
heterozygous de novo 0.9 Mb 19p13.12 microduplication
harboring 20 validated RefSeq genes in a single patient.
Whole mount in situ hybridization (WISH) analysis was
performed on mouse embryos to investigate ventrocaudal
expression of the transcripts encoded at gestational days
9.5 and 10.5. This period is the equivalent of human
gestational weeks 4 to 6 (O’Rahilly, 1979), which is the
postulated time of BEEC organogenesis in humans
(Wood et al., 2003). According to its expression pattern,
the WIZ (widely interspaced zinc finger motifs) gene
seemed to be the most promising candidate encompassed
by the duplication observed, and, hence, we investigated
all the 110 patients for the presence of WIZ mutations.
MATERIALS AND METHODS
Patients and DNA Isolation
The sample originally contained 112 BEEC patients. In
two of these patients, a 22q11.2 microduplication was
identified (Draaken et al., 2010), and these patients were
excluded from the present study. All patients (n 5 110; E
n 5 8, CBE n 5 95, CE n 5 7) were of Central European
origin and all reported an unremarkable family history.
Written informed consent was obtained from all patients
and parents before study entry, and the study was
approved by the Ethics Committee of the Medical Faculty
of the University of Bonn.
Blood or saliva samples were obtained from the
patients and (if available) their parents. In 91 patients,
both parents were available; in 15 patients, only one
parent agreed to participate; and in four patients, no
parental sample could be obtained.
Isolation of genomic DNA was carried out by a
Chemagic Magnetic Separation Module I (Chemagen,
Baesweiler, Germany) or, in the case of saliva samples,




BeadChip (Illumina, San Diego, California), which con-
tain 657,366 and 1,140,419 markers, respectively, were
used for molecular karyotyping. QuantiSNP (v2.2,
www.well.ox.ac.uk/QuantiSNP/) was used to identify
potential CNVs. All CNV calls with a size >30 kb and a
log Bayes factor of <7 (Engels et al., 2009), or which
included less than three single nucleotide polymorphisms
(SNPs), were discarded. Detected aberrations were then
compared with the CNVs identified in our internal
datasets using Cartagenia Bench software (v4.0, Leuven,
Belgium). We used CNV data from a total of 730 anony-
mous individuals with diagnoses unrelated to BEEC,
who had been genotyped using the same arrays. All
CNV regions showing complete overlap with more than
three controls were discarded. The remaining CNVs were
screened for gene content by accessing the UCSC human
genome browser assembly hg18, and by entire coverage
with known CNVs listed in the Database of Genomic
Variants (DGV; http://projects.tcag.ca/variation/) or
Decipher (http://decipher.sanger.ac.uk/). Following these
filter steps, the remaining CNVs were checked visually in
GenomeStudio v2011.2, (Illumina, San Diego, CA).
Quantitative PCR
Confirmation of the identified CNVs as well as paren-
tal genotyping was carried out by qPCR. All reactions for
qPCR were performed on an ABI Prism 7900HT Fast
Real-Time PCR System with SYBR Green (Applied Bio-
systems, Foster City, USA) for detection as previously
described (Draaken et al., 2011). Primers used for verify-




GAAGTCT-3’), and CYP4F11 (3F-5’-AGGCACTGAGCTC
CAAGATG-3’, 3R-5’-CTAGCTGCTGGTGAGAGGTG-3’).
Paternity Testing
Paternity testing was performed with the PowerPlex 16
System (Promega, Madison, WI) allowing co-amplifica-
tion and three-color detection of 16 loci according to the
manufacturer’s specifications.
WISH of Mouse Embryos
Mouse embryos of a wildtype NMRI background were
dissected into ice-cold phosphate-buffered saline (PBS),
fixed overnight in 4% paraformaldehyde (PFA)/ PBS,
and then processed for in situ hybridization as described
by Chotteau-Lelie´vre et al. (2006). Digoxigenin-labeled
antisense RNA probes were transcribed in vitro from
PCR products generated either from a mouse E10.5
cDNA library or from our in-house MAMEP collection
(Molecular Anatomy of the Mouse Embryo Project
(http://mamep.molgen.mpg.de). For murine Wiz, a 946
bp PCR product covering transcript variants 1, 2, and 3
(nucleotides 1610–2555 of GenBank accession number
NM_212438.3) was used. The primers contained T7 and
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T3 promoter sites that facilitated the generation of anti-
sense and sense probes, respectively. Riboprobes were
synthesized using the appropriate RNA polymerase and
a nucleotide mix containing digoxigenin-11-UTP (Roche).
Probes were purified using G-50 sephadex columns (GE-
Healthcare). Following probe hybridization and washes,
an anti-DIG antibody conjugated to alkaline phosphatase
(AP; Roche) was incubated with embryos overnight at
48C, and detection of AP activity was carried out using
BM Purple (Roche). For each probe, embryos were proc-
essed concurrently and staining reaction times were
maintained between embryos, to limit variation in signal
intensity. At least three embryos were examined for each
gene and stage. Figures depict representative staining.
Images were captured using AxioVision software (Zeiss)
with a Zeiss AxioCam and SteREO Discovery.V12 micro-
scope.
Histological Analyses of Mouse Embryos
Embryos were dissected and fixed overnight in 4%
PFA/PBS as above, followed by processing into paraffin
wax. In situ hybridization was performed on paraffin sec-
tions (5 lm) using the respective antisense probe accord-
ing to the protocol from Chotteau-Lelie´vre et al. (2006)
with minor modifications, and detection of AP activity
was visualized using BM Purple (Roche). Following
staining, slides were quickly dehydrated in 80% and then
100% ethanol, cleared twice for 1 min in xylene (Roth)
and coverslips were mounted with Entellan mounting
medium (Merck). Photographs were taken using AxioVi-
sion software (Zeiss) with a Zeiss AxioCam and SteREO
Discovery.V12 microscope. Three sections from at least
two different embryos were analyzed for each stage
shown and representative images are provided.
Sequence Analysis
Analysis of the coding exons of the human WIZ gene
was performed using polymerase chain reaction (PCR),
and PCR-amplified DNA products were subjected to
direct automated sequencing (3130XL Genetic Analyzer,
Applied Biosystems, Foster City, CA) according to the
manufacturer’s specifications. The two strands of each
amplicon were sequenced with specific primers (sequences
are obtainable on request for PCR and sequencing pri-
mers). WIZ amino acid positions were numbered accord-
ing to Ensembl transcript ID ENST00000389282.
RESULTS
Array Analysis
Molecular karyotyping was performed in 110 BEEC
patients, and the initial results from QuantiSNP identi-
fied 22,586 CNVs. After Cartagenia bench filtering, 221
variations remained. A stringent filtering step to remove
all known CNVs deposited either in the databases or our
own controls, along with a manual check of the aberra-
tions in the chromosome view in Genome-Studio,
reduced the list to 14 candidate variations. To verify
these remaining heterozygous 14 CNVs (eight deletions,
six duplications), qPCR was performed. These analyses
established four false positive deletions and revealed
transmission from a healthy parent in eight patients
(maternally transmitted, five cases; paternally transmit-
ted, three cases). In one patient, the duplication was
transmitted either from his mother or from his father, as
both parents were heterozygous for the duplication. A de
novo origin of a duplication could be proven in one
female with CBE.
This de novo duplication involving chromosomal
region 19p13.12 had an estimated size of 0.9 Mb and
comprised 697 consecutive markers on the array (Fig. 1).
The first and last duplicated markers were SNP19-
14944640 at genomic position 14,944,640 and rs6512075 at
genomic position 15,888,067, respectively, according to
UCSC human genome browser assembly build 18 (hg18).
The flanking markers were rs10401807 at genomic posi-
tion 14,932,009, and rs12973181 at genomic position
15,903,258. The breakpoint regions can, therefore, be
defined as ranging from position 14,932,010 to 14,944,639
and 15,888,068 to 15,903,257, respectively. qPCR analysis
confirmed this observation and revealed that this rear-
rangement was absent in the parents. Paternity testing
revealed no incompatibility with the genotypes in this
family, thus indicating a de novo event (data not shown).
There were gene interruptions at both breakpoints,
affecting the excitatory amino acid transporter gene
(EAAT4 or SLC1A6) and the gene encoding cytochrome
P450 4F11 (CYP4F11). Array data revealed two additional
imbalances in this patient. However, both a 1 Mb dupli-
cation on chromosome 17q25.1 (first and last duplicated
markers: rs1585804, rs1699607), and a 95.5 kb deletion at
1q32.1 (first and last deleted markers: rs17006055,
rs2245510) turned out to be of maternal origin (data not
shown).
WISH Analysis
The duplicated region on chromosome 19, harbors 20
validated RefSeq genes (including the two genes inter-
rupted by the rearrangement) and three noncoding
RNAs. To obtain a comprehensive overview of their tran-
scriptional activity during development of the external
genitalia, we performed WISH for the mouse orthologous
genes on embryos at gestational days (GD) 9.5 and 10.5,
with particular emphasis on the ventrolateral trunk. We
were unable to amplify mouse genes Olfr63 (human (h)
OR10H3), Cyp4f40 (hCYP4F11), Cyp4f15 (hCYP4F2), Ephx3
(hEPHX3), and Rasal3 (hRASAL3) from embryonic cDNA
libraries between E9.0 and E11.0, and, hence, it is
unlikely that these genes are expressed at significant lev-
els during embryogenesis; so they were not investigated
further. In addition, the human genes CYP4F24, UCA1,
and CYP4F1 in this region have no mouse orthologs and
thus could not be analyzed by WISH. Table 1 summa-
rizes the results obtained from successful WISH analyses
on the remaining genes. Although some genes showed
no expression at these stages, several transcripts could be
ubiquitously detected (verified using probes to detect the
sense transcript). Only transcripts for orthologs of human
CASP14, AKAP8, SYDE1, BRD4, CYP4F22, and WIZ were
found to be specifically expressed in the hindgut and/or
caudal region. Here, Akap8, Syde1, and Brd4 were all
expressed mainly ubiquitously at GD 9.5, and in cloacal
and other tissues at GD 10.5. Casp14 and Cyp4f14 (h4F12)
were expressed in the hindgut region at stage GD 9.5,
however, no expression in this region was observed at
stage GD 10.5. Similarly, Cyp4f39 (h4F22) was also
expressed in the hindgut region at GD 9.5, whereas at
GD 10.5 it was not expressed.
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Wiz expression was widely detected in the embryo
at GD 9.5 with stronger expression observed in the
neural tube, branchial arches, frontonasal process, and
forelimb bud (Fig. 2A). WISH at GD10.5 showed a sim-
ilar pattern to GD 9.5 in the maxillary and mandibular
branchial arches, fore and hindlimb buds, and tail
(Fig. 2B), with a close-up of the ventrocaudal region
illustrating Wiz expression in the developing genital
region. Given this observation, we also analyzed
midsaggital sections at GD 12.5 (Fig. 2D), GD 13.5
(Fig. 2E), and GD 14.5 (not shown). All stages showed
a similar pattern, with strong Wiz expression detectable
in the brain, frontonasal process, tail, genital tubercle,
neural tube, and lung.
Figure 1. Results of molecular karyotyping for one female CBE patient. GenomeStudio plot of whole chromosome 19 showing the dupli-
cation (red frame) involving 697 consecutive SNPs on 19p13.12 (top). Log R ratio (log R; top) represents a measure of signal intensity for
each SNP and red dots indicate the average intensity. B allele frequency (BAF; middle) denotes an allelic intensity ratio for each SNP.
The combination of increasing log R intensity and a shifted BAF suggests duplication. The RefSeq Genes (bottom) within the de novo
duplicated region identified in our patient (blue) and the flanking sides (gray) are shown from UCSC Browser (hg18). Overlapping
duplications reported by Thienpont et al. (2008) and DECIPHER (v5.1; GRCh37) are also shown.
Figure 2. Analysis of Wiz expression in midgestational mouse embryos by in situ hybridization. (A) Whole-mount of a gestational day
(GD) 9.5 mouse embryo. Expression is widely detected in the embryo with stronger expression observed in the neural tube, branchial
arches (ba), frontonasal process (fnp), and forelimb bud (flb). (B) Whole-mount at GD 10.5 shows a similar pattern to GD 9.5 in the max-
illary (mx) and mandibular (mn) branchial arches, fore and hindlimb buds (flb and hlb), and tail. (C) A close-up of the ventrocaudal
region illustrating expression in the developing genital region (ge). (D and E) Midsaggital sections at GD12.5 (D) and GD13.5 (E) show
strong expression of Wiz in the brain, frontonasal process (fnp), tail (tl), genital tubercle (gt), neural tube (nt), and lung (lu). Wiz tran-
scripts were undetected in the heart (ht) at all stages examined. Insets in (A) and (B) show embryos hybridized with a sense probe.
Note that the area of staining marked by an asterisk in B is due to trapping. The scale bar corresponds to 400 lm. fb, forebrain; mb,
midbrain; st, striatum.
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Candidate Gene Analysis
Examination of all WIZ exons and their adjacent splice
sites failed to reveal any likely causative sequence variant
in the WIZ genes from our patient samples.
A total of nine sequence variants were detected, which
were all unlikely to be causative for the occurrence of
BEEC. Five rare variants which had previously been
identified and deposited in dbSNP Build 136 (synony-
mous coding: rs62115899, rs141499743, rs117240920; non-
synonymous coding: rs79917926, rs113267381) were each
detected once among our patients, and one previously
known common variant (rs929613) was found. With the
exception of rs117240920, all variants displayed similar
frequencies as reported in the databases. For rs117240920
a minor allele (T) frequency of 0.04 was found in our
patient sample, compared to reported frequencies of
0.008 to 0.022. The rare variants present in databases
were considered to be unlikely causative for BEEC given
the low prevalence of the malformation and they were,
therefore, not followed up for parental inheritance.
Four rare variants were not present in databases: three
nonsynonymous variants (c.G544A, p.Asp182Asn;
c.G1132C, p.Glu378Gln; c.C4436T, p.Pro1479Leu), with
one of them inherited from a healthy father (c.G544A)
and two inherited from a healthy mother (c.G1132C;
c.C4436T), and a synonymous variant (c.C4377T,
p.Gly14595) for which the transmission was not investi-
gated. Using several SNP function prediction algorithms,
all non-synonymous variants (previously known and
newly identified) were classified as benign.
DISCUSSION
Based on genome-wide analyses, recent studies have
identified a broad number of CNVs associated with
human disorders (Vermeesch et al. 2011). However, the
great majority of CNVs are neutral variants and it often
proves difficult to implicate a specific CNV in disease de-
velopment. Most important evidence for a causal rela-
tionship is de novo occurrence in a patient. Further im-
portant support is provided through independent obser-
vation of an identical or overlapping CNV in additional
patients. Even more straightforward to the level of the
causative gene is the identification of mutations in a gene
from the CNV region in patients.
The de novo 19p13.12 duplication detected in our
female patient is associated with isolated CBE without
any other abnormal features. We are aware of only one
published report on a chromosomal rearrangement
involving band p13.12 (Thienpont et al. 2008). In this
report, the affected female presented with microcephaly,
velopharyngeal insufficiency, mental retardation, dys-
morphism, and a muscular ventricular septal defect but
without any genitourinary involvement (Table 2). Com-
pared with the duplication detected in our CBE patient,
only one region of overlap could be identified which
comprises the proximal part, ranging from the loci
encoding CYP4F8 to CYP4F11 (Fig.1). However, in the
aberration established by Thienpont et al. (2008), this
fragment was found to be triplicated, followed by dupli-
cation and again a triplication. Furthermore, the Database
of Chromosomal Imbalance and Phenotype in Humans
(DECIPHER; v5.1) lists two patients showing a similar
duplication to that observed in our case. Here, a com-
pletely different phenotype including macrocephaly and
cognitive and behavioral impairments was reported, and
one of these patients also showed craniofacial and limb
anomalies (Table 2). These phenotypic differences may be
attributable to the orientation of the duplication (in tan-
dem or inverse), which is still unknown in all four cases.
Conversely, the completely different features in patients
sharing a similar aberration reflect the observations made
for various other CNVs (e.g., duplication 22q11.21) show-
ing extreme variability in expression and penetrance
(Draaken et al., 2010).
In our case, two further heterozygous aberrations were
identified in the patient, which we assumed were
not causally related to the CBE phenotype. Aside from
their maternal inheritance in both the cases, the 1 Mb
Table 1
Expression Patterns of Duplicated Genes Contained on 19p13.12 in Mouse Embryos at GD9.5 and GD10.5
Gene
Mouse
ortholog Expression at GD9.5 Expression at GD10.5
SLC1A6 Slc1a6# None None
CASP14 Casp14 Hindgut Eye
SYDE1 Syde1# Ubiquitous Restricted to limb buds, tail (cloacal membrane
included), branchial arches, frontonasal process (FNP)
ILVBL Ilvbl None None
NOTCH3 Notch3# Ubiquitous, stronger in neural tissues Ubiquitous, stronger in neural tissues
BRD4 Brd4# Ubiquitous, stronger in FNP,
branchial arches, and limb buds
Ubiquitous, stronger in limb buds, tail (cloacal membrane
included), branchial arches, and FNP
AKAP8 Akap8# Ubiquitous Restricted to limb buds, tail (cloacal membrane included),
branchial arches, FNP
WIZ Wiz Ubiquitous with higher expression
in the caudal region
Higher expression in the caudal region, neural tube,
branchial arches, and limb buds
PGLYRP2 Pglyrp2# ubiquitous Ubiquitous
CYP4F22 Cyp4f39 Hindgut None
CYP4F8 Cyp4f17 None None
CYP4F16 Cyp4f16# Ubiquitous Ubiquitous
CYP4F12 Cyp4f14 Weak ubiquitous, tailgut Weak ubiquitous, intersomitic
CYP4F11 Cyp4f40# None None
#Expression data listed were either obtained using probes from the MAMEP database (#) or from probes generated during the course
of this study.
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duplication on chromosome 17q25.1 seems to be a benign
variant, since studies using various control population
cohorts have observed chromosomal gains comprising
this region (Pinto et al., 2007; Simon-Sanchez et al., 2007;
Zogopoulos et al., 2007; Itsara et al., 2009). The observed
95.5 kb deletion at 1q32.1 interrupts the gene encoding
cathepsin E, an endolysosomal aspartic proteinase, pre-
dominantly expressed in cells of the immune system
(Yanagawa et al., 2007), gastric mucosal cells, and epider-
mal keratinocytes (Kawabuko et al., 2011). However, the
complete cathepsin E knockout in mice resulted only in a
lysosomal storage disorder in macrophages and an
increased susceptibility to bacterial infection (Yanagawa
et al., 2007). Taken together, these data support the
assumption that a dosage effect of a gene distal to
CYP4F11 (Fig. 1) might be causally related to BEEC.
Finally, one hypothesis, yet to be verified, may explain
the phenotypic differences observed in our patient and
others showing a gain of 19p13.12 material. The break-
points of the duplication in our patient cause gene inter-
ruptions for the genes EAAT4 (SLC1A6) and CYP4F11.
Although both genes affected show no expression at
GD9.5 and GD10.5, a fusion protein containing parts of
both these genes might interfere with early embryonic
development at the time when the morphogenetic events
leading to CBE occur. Unfortunately, RNA from the
patient was unavailable to perform the analyses required
to confirm this hypothesis. It also remains to be eluci-
dated to what degree the postnatal finding of such a
fusion-transcript would reflect the situation during
embryogenesis.
Spatiotemporal analysis of gene activity in the mouse
embryo provides important information regarding the
possible function of a gene in a given developmental pro-
cess. Hence, we performed a detailed expression analysis
of the genes comprised by the de novo 19p13.12 duplica-
tion. Our analysis (Table 1), which focused on the ventro-
caudal trunk region during the developmental stages that
are critical for the development of the malformations of
the BEEC, showed that Wiz is strongly expressed in the
relevant tissues—in particular, the cloacal membrane and
genital tubercle. The embryonic etiology of bladder exs-
trophy is unknown, but it has been suggested that it may
derive from an abnormally long cloacal membrane (Mar-
shall and Muecke, 1962), or more recently from cranially
displaced genital tubercle outgrowth (Kulkarni and
Chaudhari, 2008). Wiz in its role as a transcription factor
is expressed in both the cloacal membrane and genital tu-
bercle during the relevant stages of development for the
occurrence of exstrophy. This suggests that an imbalance
in expression resulting from duplication/deletion may
have relevant phenotypic effects, and, hence, we consid-
ered it a reasonable candidate for involvement in normal
and abnormal genital formation.
Although one might expect a duplication to result in a
subtle increase in transcript level, there is multiple evi-
dence that duplications and deletions as well as point
mutations affecting a single gene can result in a similar
Table 2









dup 19p13.11 (1.3 Mb)
yes









and 0.8 Mb) yes
2 2 dup 17q25.1 (1 Mb);




1 Tall stature, proportionate 2 2
Brain Normal MRI nrb nrb ndc
Cranium Microcephaly Macrocephaly Macrocephaly 2




High palate, frontal bossing,
long philtrum, small ears,







1 1 1 2
Ophthalmologic Strabismus 2 2 2




short and broad toes, flat
arches of feet
2 2






soft skin, joint laxity,
gynaecomastia
Scoliosis 2
(1) Present; (2) absent.
aIUGR, intrauterine growth retardation.
bnr, not reported.
cnd, not done.
dVSD, ventricular septal defect.
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phenotype. For instance, TBX1 truncation mutations as
well as TBX1 missense mutations, resulting in a gain of
function, have been observed in patients with DiGeorge
syndrome (DGS; Yagi et al., 2003; Zweier et al., 2007).
These mutations reflect the data obtained from mouse
models, in which the full spectrum of DGS malformations
has been elicited in a Tbx1 dose-dependent manner
through either overexpression or underexpression (Liao
et al., 2004). Also, an association between microdeletion or
microduplication at 16p11.2 and autism has been observed
(Weiss et al., 2008), and dysmorphic features and a Rett
syndrome-like clinical course were found in the presence
of a FOXG1 duplication as well as a deletion (Florian
et al., 2012). These observations prompted us to investigate
WIZ for the presence of mutations in our patient cohort.
However, our screening identified no likely causative
mutations in the coding regions or exon–intron boundaries
of human WIZ in the sample of 110 BEEC patients. It is,
therefore, unlikely that mutations affecting the WIZ gene
are a frequent cause of CBE and/or BEEC; however, our
patient cohort might have been too small to detect rare
causal mutational events. Furthermore, we may have
missed mutations in the promoter region, in as yet
unknown regulatory sequences, or in noncoding regions
not detectable using the method applied.
In summary, our study showed CBE to be associated
with a 0.9 Mb 19p13.12 duplication. WISH analysis of the
genes encompassed by the duplication revealed WIZ as a
plausible candidate to be involved in the development of
the urogenital system. Our mutation screening study,
however, could not confirm that mutations affecting
human WIZ are a frequent cause of BEEC. Independent
studies are necessary to further verify that a gene dosage
effect involving chromosomal region 19p13.12 predis-
poses to the manifestation of the BEEC.
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